Sanofi | SNY - Debt




Sanofi reported 23.75B in Debt for its fiscal quarter ending in June of 2024.

Debt Change Date
AbbVie USD 71.08B 445M Sep/2024
Amgen USD 60.1B 299M Dec/2024
AstraZeneca USD 30.3B 1.27B Dec/2024
Bristol-Myers Squibb USD 49.65B 103M Dec/2024
Canopy Growth CAD 613.52M 10.01M Sep/2024
Corcept Therapeutics USD 6.79M 1.12M Sep/2024
Drreddys Laboratories INR 48.54B 17.87B Sep/2024
Eli Lilly USD 31.12B 2.23B Sep/2024
Galapagos EUR 11.46M 592K Sep/2024
Genmab DKK 1.03B 42M Dec/2024
GlaxoSmithKline GBP 16.99B 927M Dec/2024
Glaxosmithkline GBP 16.06B 884M Sep/2024
Indivior 284M 3M Sep/2024
J&J USD 35.75B 5.74B Sep/2024
Merck USD 38.13B 343M Sep/2024
Novartis USD 31.26B 828M Dec/2024
Novartis USD 32.16B 3.23B Sep/2024
Pacira USD 644.42M 4.17M Sep/2024
Perrigo USD 4.75B 695.7M Sep/2024
Pfizer USD 66.62B 2.06B Sep/2024
Prestige Brands USD 996.95M 54.86M Dec/2024
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 23.75B 5.33B Jun/2024
Sanofi 23.75B 5.33B Jun/2024
Supernus Pharmaceuticals USD 38.15M 1.82M Sep/2024
UCB EUR 3.04B 1000K Jun/2024
Zoetis USD 6.57B 185M Dec/2024